U.S. and Chinese researchers appear to have unlocked a novel way to stop T cells from attacking the body in MS and other ...

Autoimmune diseases, such as multiple sclerosis (MS), inflammatory bowel disease (IBD), and rheumatoid arthritis (RA), affect ...

Regulatory T cells suppress inflammation and are defective in autoimmune diseases. A recent study provides new insight into how these cells become dysregulated in multiple sclerosis and points to a ...

When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered ...

New research has identified the gene Egr-1 as a critical regulator of immune balance, offering hope for autoimmune disease therapies.

Multiple sclerosis, an autoimmune disorder, is known to be driven by 'helper' T cells, white blood cells that mount an inflammatory attack on the brain and spinal cord. A new study pinpoints the ...

Misguided killer T cells may be the missing link in sustained tissue damage in the brains and spines of people with multiple sclerosis. Mouse studies showed that killer T cells were activated and ...

BOSTON — A new approach to the treatment of multiple sclerosis (MS) — use of T cells sensitized to the Epstein-Barr virus — has shown encouraging results in a preliminary study. The study ...

In a rare glimpse inside a diseased brain, researchers watch for the first time as immune cells directly attack neurons in a mouse model of multiple sclerosis (MS).

The University of Cincinnati joins a Phase 1 clinical trial testing CAR-T cell therapy for MS, exploring this cancer ...

Share on Pinterest New research points to T cells as a potential avenue for new MS treatments. Luis Velasco/Stocksy Multiple sclerosis (MS) is a disease where the immune system attacks the central ...

But when you have MS, B cells recruit T cells into your brain. There, they cause inflammation. When your number of B cells goes down, your amount of T cells that cause inflammation goes down, too.